关注
Bharath Kumar Chagaleti
Bharath Kumar Chagaleti
其他姓名Bharath Kumar C, C.Bharath Kumar
PhD Research Scholar, SRM College of Pharmacy, SRM Institute of Science and Technology
在 srmist.edu.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Exploring cyclin-dependent kinase inhibitors: a comprehensive study in search of CDK-6 inhibitors using a pharmacophore modelling and dynamics approach
BK Chagaleti, V Saravanan, C Vellapandian, MK Kathiravan
RSC Advances 13 (48), 33770-33785, 2023
92023
Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX
V Saravanan, BK Chagaleti, SD Packiapalavesam, M Kathiravan
RSC advances 14 (5), 3346-3358, 2024
82024
An overview of mechanism and chemical inhibitors of shikimate kinase
BK Chagaleti, MBR Reddy, V Saravanan, P Senthil Kumar, ...
Journal of Biomolecular Structure and Dynamics 41 (23), 14582-14598, 2023
42023
In silico Design and Synthesis of Some New Imidazole Derivatives for Tuberculosis
BSK Ashutosh Jena, C. Prakashraj, Bharath Kumar Chagaleti, M. K. Kathiravan
Indian Journal of Heterocyclic Chemistry 33 (1), 43-49, 2022
4*2022
Discovery and development of COVID‐19 vaccine from laboratory to clinic
V Saravanan, BK Chagaleti, PL Narayanan, VB Anandan, H Manoharan, ...
Chemical Biology & Drug Design, 2023
32023
Design synthesis and biological evaluation of thiophene 2-pentafluoro benzamide derivatives as antitubercular agent
B Shanthakumar, V Saravanan, BK Chagaleti, MK Kathiravan
32023
Prospection of microfluidics for local drug delivery
NR Naveen, D Girirajasekhar, PS Goudanavar, CB Kumar, GL Narasimha
Current Drug Targets 23 (13), 1239-1251, 2022
22022
Imidazooxazine moiety as polyketide synthase 13 inhibitors targeting tuberculosis
B Shanthakumar, P Gopinath, BK Chagaleti, V Saravanan, ...
Journal of King Saud University-Science 36 (6), 103220, 2024
12024
Targeting cyclin-dependent kinase 2 CDK2: Insights from Molecular Docking and Dynamics Simulation-A systematic computational approach to discover novel cancer therapeutics
BK Chagaleti, BS Kumar, R Rajagopal, A Alfarhan, J Arockiaraj, ...
Computational Biology and Chemistry, 108134, 2024
12024
Design, Synthesis, and Docking Studies of Some New 5-(([1, 1'-Biphenyl]-4-yloxy) methyl)-2-(N-methylene) amino-1, 3, 4-thiadiazoles as Anti-inflammatory Agents
L Pranathi, CB Kumar, AA Kumar, KV Devi
INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY 32 (4), 461-468, 2022
12022
The synthetic approach of benzimidazole derivatives as anti-inflammatory agents
J Jahan, S Barik, BK Chagaleti, MK Kathiravan, P Deivasigamani
inflammation 14, 19, 0
1
Multitargeted molecular docking and dynamics simulation of thymol-based chalcones against cancer protein markers: Synthesis, characterization, and computational study
Y Laamari, A Bimoussa, F Mourad, BK Chagaleti, V Saravanan, ...
Journal of Molecular Structure 1317, 139116, 2024
2024
Thymol-1, 2, 3-triazole derivatives: Network Pharmacology, Molecular Simulations and Synthesis Targeting Breast Cancer
Y Laamari, A Bimoussa, BK Chagaleti, V Saravanan, SH Alotaibi, ...
Journal of Molecular Structure, 140060, 2024
2024
2, 4-Substituted Oxazolones: Antioxidant Potential Exploration
A Thanvi, BK Chagaleti, R Srimathi, MK Kathiravan, B Shanthakumar
Journal of Young Pharmacists 16 (2), 244-251, 2024
2024
Molecular modeling studies of Pyrazolopyrimidine Derivatives as potent Cyclin Dependent Kinase-2 inhibitors
BK Chagaleti
2024
Textbook of Pharmaceutical Chemistry for First Year Diploma in Pharmacy as per New Syllabus PCI-ER 2020
P Nayanapalli, BK Chagaleti, M Shaik
Published by Evincepub Publishing, 272 pages, 2022
2022
Synthesis of novel Thiazolidinone derivatives as a potential PPAR Gamma agonist for Anti-diabetic activity
IN Patent App. 202241043672 A, 2022
2022
The Ear formulations and treatment methods for treating Ear deafness using Intratympanic composition
IN Patent App. 202241062256 A, 2022
2022
Role of Pyridine Containing Azetidinone Derivatives as Privileged Scaffolds in Anti Tubercular Agents
N Pramod, CB Kumar, P Lekha, B Mayuri
Book Publisher International (a part of SCIENCEDOMAIN International), 2021
2021
Therapeutic Nanoparticles for the treatment of Cancer
DE Patent App. 20 2022 101 544, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20